We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

155 hedge funds and large institutions have $130M invested in Definium Therapeutics in 2021 Q2 according to their latest regulatory filings, with 155 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more call options, than puts

Call options by funds: $9.65M | Put options by funds: $6.68M

0.74% more ownership

Funds ownership: 0% → 0.74% (+0.74%)

Holders
155
Holders Change
+155
Holders Change %
–
% of All Funds
2.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
155
Increased
–
Reduced
–
Closed
–
Calls
$9.65M
Puts
$6.68M
Net Calls
+$2.97M
Net Calls Change
+$2.97M

Top Buyers

1
BlackRock
BlackRock
New York
+$54.9M
2
State Street
State Street
Massachusetts
+$15.7M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$9.49M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$5.84M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.33M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SIAP
151
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
– +$105 +2 New
MA
152
Montag & Associates
Georgia
– +$210 +4 New
PP
153
PrairieView Partners
Minnesota
– +$210 +4 New
HR
154
Howe & Rusling
New York
– +$262 +5 New
FFG
155
Ford Financial Group
California
– +$682 +13 New
3 4 5 6
7

DFTX Hedge Fund Activity: Q2 2021 in Review

155 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q2 2021, worth a combined $130M.

Buyers outnumbered sellers: 155 funds opened new DFTX positions and 0 closed out — a net gain of 155 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $54.9M.

  • 155 institutional investors held Definium Therapeutics (DFTX) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $130M of Definium Therapeutics stock for Q2 2021.
  • 155 funds opened new Definium Therapeutics positions in Q2 2021 and 0 closed out, a net change of +155 holders.
  • The largest Definium Therapeutics buyer in Q2 2021 was BlackRock, an estimated $54.9M added.

Based on aggregated 13F filings for Q2 2021.